偏头痛的药物治疗及作用机制  

Drug Therapy and Mechanism of Migraine

作　　者：郭承承[1] GUO Cheng-cheng(Department of Neurology,Tianjin First Central Hospital,Tianjin 300192,China)

机构地区：[1]天津市第一中心医院神经内科,天津300192

出　　处：《医学信息》2022年第9期81-83,共3页Journal of Medical Information

摘　　要：偏头痛是临床最为常见的原发性头痛类型,该病的发病机制尚不明确,其治疗多以药物治疗为主,包括急性发作期治疗与发作间期的预防性治疗,前者旨在控制症状,后者则多以减少发作频率、缩短发作时间为目的。近年来,临床对于偏头痛的病理生理学研究推动了新的靶向治疗进展。基于此,本文对该病的药物治疗进展进行阐述,可供临床参考。Migraine is the most common type of primary headache in clinic,the pathogenesis of migraine is still unclear.The treatment of migraine is mainly based on drug therapy,including acute attack treatment and preventive treatment of interictal period.The former aims to control symptoms,and the latter is more to reduce the frequency of attacks and shorten the attack time.In recent years,the pathophysiology of migraine has promoted new targeted therapies.Based on this,this paper expounds the progress of drug treatment of the disease,which can be used for clinical reference.

关 键 词：偏头痛 药物治疗 降钙素基因相关肽 5-羟色胺受体激动剂 钙离子通道阻滞剂 

分 类 号：R747.2[医药卫生—神经病学与精神病学]